Lexeo Therapeutics (LXEO) Liabilities and Shareholders Equity (2022 - 2026)
Lexeo Therapeutics (LXEO) reported Liabilities and Shareholders Equity of $254.9 million for Q2 2026, up 44.8% from $176.07 million a year earlier and up 1.8% from the prior quarter.
Powered by 
Analysis
Lexeo Therapeutics (LXEO) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends
At the end of FY2025, Lexeo Therapeutics posted Liabilities and Shareholders Equity of $268.69 million, up 82.9% from FY2024.
- Liabilities and Shareholders Equity has increased for three consecutive years, with a three-year compound annual growth rate of 40.4% (FY2022 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $146.94 million in FY2024 (+5.1%), $139.81 million in FY2023 (+44.0%) and $97.08 million in FY2022.
- Five-year quarterly Liabilities and Shareholders Equity spans a low of $54.72 million in Q3 2023 and a high of $268.69 million in Q4 2025.
- Year over year, Liabilities and Shareholders Equity has now increased in each of the last three quarters, with growth averaging 47.9% over the last eight quarters.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was Q3 2024 (growth of 217.7%); the low point was Q1 2025 (a decline of 41.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $250.36 million (Q1 2026), $268.69 million (Q4 2025) and $143.84 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Lexeo Therapeutics | 265.74 Mn | 265.74 Mn | - | 254.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 254.90 Mn |
| Mar 31, 2026 | 250.36 Mn |
| Dec 31, 2025 | 268.69 Mn |
| Sep 30, 2025 | 143.84 Mn |
| Jun 30, 2025 | 176.07 Mn |
| Mar 31, 2025 | 125.69 Mn |
| Dec 31, 2024 | 146.94 Mn |
| Sep 30, 2024 | 173.87 Mn |
| Jun 30, 2024 | 192.01 Mn |
| Mar 31, 2024 | 213.21 Mn |
| Dec 31, 2023 | 139.81 Mn |
| Sep 30, 2023 | 54.72 Mn |
| Dec 31, 2022 | 97.08 Mn |
API Access
Lexeo Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=LXEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "LXEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=LXEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();